San Antonio pharmaceutical firm Azaya Therapeutics Inc. has accused its founder and his new company of swiping a patent that's the basis of Azaya's efforts at developing safer cancer treatments. Azaya ...
Cytori Therapeutics is set to gain cancer drugs and a liposomal nanoparticle technology platform through the acquisition of Azaya Therapeutics. The lead drug is a formulation of doxorubicin, the ...
Cytori Therapeutics said today it plans to acquire the liposomal nanoparticle technology platform of Azaya Therapeutics for up to $170 million, in a deal designed to expand and complement the buyer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results